We present a pediatric case of a rapidly expanding third ventricle germ cell tumor (GCT). A 14-year-old boy suffered from gradual-onset central diabetes insipidus (DI) and received desmopressin treatment. Magnetic resonance imaging (MRI) showed nonspecific findings of the pituitary-hypothalamic axis. Nine months after the initial DI diagnosis, he developed progressively worsening headache. MRI demonstrated a third ventricle tumor causing noncommunicating hydrocephalus, although an MRI 16 weeks before admission did not show the lesion. We performed gross total resection (GTR) of the tumor in 2 stages: a translamina terminalis approach and an extended transsphenoidal approach. The lesion was histologically diagnosed as immature teratoma with some germinoma. His noncommunicating hydrocephalus resolved after surgery. Through postoperative radiochemotherapy (whole ventricle: 23.4 Gy/13 fractions, tumor bed: 27.0 Gy/15 fractions, and 3 courses of carboplatin-etoposide), he has was in complete remission at the 3-year follow-up and has continued his high school program. This case suggests the following: (1) a mixed GCT originating from the neurohypophysis/infundibulum can show rapidly expansive growth in a child with central DI; (2) GTR and adjuvant radiochemotherapy can result in a good therapeutic outcome in rapidly expanding GCT; and (3) the extended transsphenoidal approach is a complementary approach to transcranial resection of anterior third ventricle GCTs.

1.
Jennings MT, Gelman R, Hochberg F: Intracranial germ cell tumours. Natural history and pathogenesis. J Neurosurg 1985;63:166-167.
2.
Kakkar A, Biswas A, Kalyani N, Chatterjee U, Suri V, Sharma MC, Goyal N, Sharma BS, Mallick S, Julka PK, Chinnaswamy G, Arora B, Sridhar E, Chatterjee S, Jalali R, Sarkar C: Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India. Childs Nerv Syst 2016;32:2173-2180.
3.
Jinguji S, Fukuda M, Nagasaki K, Fujii Y: A pineal region germ cell tumor with rapid enlargement after a long-term follow-up: case report. Neurosurgery 2013;72:E687-E693.
4.
Villodre ES, Kipper FC, Pereira MB, Lenz G: Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treat Rev 2016;51:1-9.
5.
Kaufhold S, Garbán H, Bonavida B: Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res 2016;35:84.
6.
Konovalov AN, Gorelyshev SK: Surgical treatment of anterior third ventricle tumours. Acta Neurochir (Wien) 1992;118:33-39.
7.
Lan Q, Dong J, Huang Q: Minimally invasive keyhole approaches for removal of tumors of the third ventricle. Chin Med J (Engl) 2006;119:1444-1450.
8.
Charalampaki P, Filippi R, Welschehold S, Conrad J, Perneczky A: Tumors of the lateral and third ventricle: removal under endoscope-assisted keyhole conditions. Neurosurgery 2005;57:302-311.
9.
Schroeder HW: Intraventricular tumors. World Neurosurg 2013;79:S17.e15-e19.
10.
Baldauf J, Hosemann W, Schroeder HW: Endoscopic endonasal approach for craniopharyngiomas. Neurosurg Clin N Am 2015;26:363-375.
11.
Shono T, Natori Y, Morioka T, Torisu R, Mizoguchi M, Nagata S, Suzuki SO, Iwaki T, Inamura T, Fukui M, Oka K, Sasaki T: Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas. J Neurosurg 2007;107(3 suppl): 193-198.
12.
Maghnie M: Diabetes insipidus. Horm Res 2003;59(suppl 1):42-54.
13.
Ghirardello S, Malattia C, Scagnelli P, Maghnie M: Current perspective on the pathogenesis of central diabetes insipidus. J Pediatr Endocrinol Metab 2005;18:631-645.
14.
Mootha SL, Barkovich AJ, Grumbach MM, Edwards MS, Gitelman SE, Kaplan SL, Conte FA: Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997;82:1362-1367.
15.
Tonni G, Grisolia G, Nanni M, De Martino A, Villani P, Zampriolo P: A rare immature teratoma of the tela chorioidea of the third ventricle: late-onset, intrapartum ultrasound diagnosis and postnatal outcome. Childs Nerv Syst 2014;30:1743-1747.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.